Valbiotis Overview

  • Founded
  • 2014
Founded
  • Status
  • Public
  • Employees
  • 35
Employees
  • Stock Symbol
  • ALVAL
Stock Symbol
  • Share Price
  • $7.15
  • (As of Monday Closing)

Valbiotis General Information

Description

Valbiotis SA is a research & development company. It is engaged in scientific innovation for preventing and combating metabolic diseases. Valbiotis has adopted an approach, aiming to revolutionize healthcare by developing a new class of Nutrition Health products designed to reduce the risk of major metabolic diseases, based on a multi-target approach by the use of plant-based ingredients.

Contact Information

Ownership Status
Publicly Held
Financing Status
Formerly VC-backed
Primary Industry
Drug Discovery
Other Industries
Pharmaceuticals
Stock Exchange
PAR
Primary Office
  • 12F rue Paul Vatine
  • 17180 Périgny
  • France

Valbiotis Timeline

2018201920202021
Financing RoundCaptured Employee CountEstimated Employee Growth
Want detailed data on 3M+ companies?

What you see here scratches the surface

Request a free trial
Want to dig into this profile?

We’ll help you find what you need

Learn more

Valbiotis Stock Performance

(As of Monday Closing)

Stock Price Previous Close 52 wk Range Market Cap Shares Average Volume EPS
$7.15 $7.18 $4.87 - $10.14 $69.6M 9.7M 8.91K -$0.59

Valbiotis Financials Summary

In Thousands,
USD
TTM 31-Dec-2020 FY 2020 31-Dec-2020 FY 2019 31-Dec-2019 FY 2018 31-Dec-2018
EV 49,852 49,852 18,779 8,219
Revenue 4,959 4,959 1,466 1,728
EBITDA (2,743) (2,743) (4,729) (5,606)
Net Income (4,365) (4,365) (6,161) (5,861)
Total Assets 25,925 25,925 16,869 13,619
Total Debt 8,616 8,616 5,350 3,205
Public Fundamental Data provided by Morningstar, Inc. disclaimer

Valbiotis Valuation & Funding

Deal Type Date Amount Valuation/
EBITDA
Post-Val Status Debt

This information is available in the PitchBook Platform. To explore Valbiotis‘s full profile, request access.

Request a free trial

Valbiotis Executive Team (6)

Name Title Board Seat Contact Info
Sébastien Peltier Co-Founder, Chairman & Chief Executive Officer
Jocelyn Pineau Co-Founder & Chief Financial Officer
Sébastien BESSY Chief Operating Officer & Chief Marketing Officer&Chief Business Officer
Pascal Sirvent Ph.D Chief Scientific Officer & Board Member
Murielle Cazaubiel CMO, Director, Development and Medical Affairs & Board Member
You’re viewing 5 of 6 executive team members. Get the full list »

Valbiotis Board Members (3)

Name Representing Role Since
Laurent Levy Ph.D Self Chairman of Supervisory Board 000 0000
Pascal Sirvent Ph.D Valbiotis Chief Scientific Officer & Board Member 000 0000
Sébastien Peltier Valbiotis Co-Founder, Chairman & Chief Executive Officer 000 0000
To view Valbiotis’s complete board members history, request access »

Valbiotis Signals

Growth Rate

0.80% Weekly
Growth
Weekly Growth 0.80%, 93rd %ile
-35.5%. 530%

Size Multiple

219x Median
Size Multiple 219x, 100th %ile
0.00x 0.95x. 413Kx

Key Data Points

Twitter Followers

5.5k

Similarweb Unique Visitors

15.0K

Majestic Referring Domains

314

PitchBook’s non-financial metrics help you gauge a company’s traction and growth using web presence and social reach.

Request a free trial

Valbiotis Investors

Investor Name Investor Type Holding Investor Since Participating Rounds Contact Info

This information is available in the PitchBook Platform. To explore Valbiotis‘s full profile, request access.

Request a free trial